Search Results

Notable Labs, Inc., a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, announced the completion of its merger transaction with VBL Therapeutics and associated financing.

VBL Therapeutics, announced that its shareholders voted to approve the previously announced proposed merger with Notable Labs, Inc., at the annual and special meeting which took place, October 12, 2023.

VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced financial results for the second quarter ended June 30, 2023, and provided a corporate update.

VBL Therapeutics, reminds its shareholders to vote in favor of the previously announced proposed merger with Notable Labs at the annual and special meeting for shareholders of record as of September 5, 2023.

VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today announced that its registration statement on Form S-4 in connection with the proposed merger with Notable Labs, Inc. (“Notable”) has been declared effective by the U.S. Securities and Exchange Commission (“SEC”).

VBL Therapeutics, announced financial results for the first quarter ended March 31, 2023, and provided a corporate update.

VBL Therapeutics (Nasdaq: VBLT) (VBL), today announced financial results for the fiscal year ended December 31, 2022, and provided a corporate update.

VBL Therapeutics (Nasdaq:VBLT), a biotechnology company developing targeted medicines for immune-inflammatory diseases, and Notable Labs, Inc. (“Notable”), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced they have entered into a definitive merger agreement.

Aleph Farms, the first company to grow cultivated steaks directly from non-modified cow cells, announced that it has acquired a manufacturing facility in Modi’in, Israel, and certain related assets from biotechnology company VBL Therapeutics.

VBL Therapeutics announced that VBL received a written notification from the Nasdaq Stock Market LLC on August 31, 2022, notifying VBL that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq.